Jason Colodne & Colbeck Capital Support the MD Anderson Cancer Center

Colbeck Capital Management is incredibly proud to renew our commitment to the MD Anderson Cancer Center at the The University of Texas at Austin in support of its relentless pursuit of advancements in cancer patient care, research, education, and prevention.

We are honored to help bolster MD Anderson Cancer Center's crucial work in clinical trials and research, targeting more effective treatments and reducing the risks associated with Anaplastic Thyroid Cancer (ATC). Through enrolling patients in clinical trials and planning for future ones, the center continues to execute on its mission: to eliminate cancer not just in Texas, but across the nation and the world.

Together, we can make a difference in the fight against cancer – let’s make cancer history!